NYU Langone and NYU Grossman in the News
New A.I. breast cancer risk tool
CBS Mornings
Celine R. Gounder, MD, clinical associate professor of medicine at NYU Grossman School of Medicine and CBS News medical correspondent, evaluates "Clariti," a newly FDA-authorized AI tool that predicts a patient's five-year breast cancer risk based on mammogram images. Dr. Gounder explains that while the FDA authorized the device, it did not require proof that acting on the tool's scores actually improves health outcomes. She warns of significant performance gaps, noting the AI performed less accurately for Black women, and lacked confirmation for patients under 50, over 65, Asian women, or those with breast implants.
10/16/2026
Busy Philipps opens up about surviving a malignant brain tumor diagnosed via elective scan
The View
Actress Busy Philipps shared her health journey on The View, revealing she was diagnosed with a malignant brain tumor after undergoing an elective full-body MRI. Despite her general practitioner initially telling her the scan wasn't necessary, Philipps followed her intuition and discovered the tumor, which caused no prior symptoms. She underwent a successful surgery at NYU Langone on March 2nd and returned to filming her show just six weeks later on April 2nd. Emphasizing the importance of early detection, she advocated for preventative screenings and universal healthcare access, noting that finding a treatable issue early is far better than ignoring potential risks out of fear.
10/16/2026
Why Giants’ return man needed season-ending surgery | The Injury Report
New York Post
Kevin Schafer, MD, a foot and ankle surgeon at NYU Langone Health, discusses the decision for New York Giants return specialist Braxton Berrios to undergo season-ending Lisfranc surgery. Dr. Schafer analyzes the nature of the injury and the reasons behind opting for the surgical procedure.
10/16/2026
A 26-year-old felt her concerns were being dismissed. Then she was diagnosed with breast cancer.
CBS News
A 26-year-old woman's breast cancer diagnosis highlights the challenges younger patients face. In an interview, Mary L. Gemignani, MD, MPH, director of the Women's Early Onset Cancer Program and chief of the Division of Breast Surgery at NYU Langone, who was not involved in the patient's care, commented on the trend. She noted that young women are often diagnosed at a later stage with more aggressive tumors and sometimes face dismissal from providers. Gemignani also explained that younger patients have unique needs, such as balancing treatment with school or work obligations.
Also reporting was: Yahoo Health, MSN New Zealand, Medical Daily
10/17/2026
Breast cancer is hitting younger women. An NYU Langone oncologist says don't wait to get checked.
amNewYork
Elizabeth Comen, MD, a medical oncologist at NYU Langone's Perlmutter Cancer Center and co-director of the Mignone Women's Health Collaborative, advises younger women not to wait to get checked for breast cancer due to a rising incidence in those under 50. She references the new U.S. Preventive Services Task Force recommendation to begin mammograms at age 40 but stresses the importance of a risk assessment with a doctor. Comen also discusses research questions, diagnostic delays in younger women, and advances at NYU Langone, where doctors use serial blood work to monitor cancer in real time.
10/17/2026
Improving hospital accountability and public health: The CHNAudit project
A Health Podyssey
The Lown Institute created the CHNAudit project to evaluate how well nonprofit hospitals meet Community Health Needs Assessment requirements. A pilot study of 26 large hospitals found that while most comply with IRS rules, many fall short on accessibility and reporting measurable outcomes. The report highlighted several hospitals that exceeded basic requirements. NYU Langone Health was specifically cited as an example for providing its executive summary in six languages. The project aims to improve hospital accountability and ensure community benefit programs align with identified health needs.
10/16/2026
The BMJ
Research from the NYU Lupus Pregnancy Cohort, based at NYU Langone Health and Bellevue Hospital sites, found that reported rates of adverse pregnancy outcomes (APOs) in women with systemic lupus erythematosus depend heavily on study inclusion criteria. The study, approved by the NYU Grossman School of Medicine Institutional Review Board, showed broader definitions and the inclusion of higher-risk patients substantially increased observed APO rates. The absence of remission during pregnancy was also linked to a higher risk of complications, underscoring the importance of personalized counseling for patients.
10/16/2026
Visual hallucinations: Don't assume it's psychiatric
Medscape
Visual hallucinations are often indicators of serious physical illnesses, not just psychiatric conditions, explains Adjoa Smalls-Mantey, MD, adjunct assistant professor of psychiatry at NYU Grossman School of Medicine. She notes that in her experience, about 80% of cases in the emergency room have a non-psychiatric cause. The article outlines a differential diagnosis for visual hallucinations, which can be caused by conditions such as diabetic retinopathy, migraines with aura, epilepsy, Lewy body dementia, brain tumors, strokes, and drug intoxication or withdrawal.
10/16/2026
Your patient has elevated oxalate. Now what?
Medscape
Amid a rise in oxalate testing, David S. Goldfarb, MD, professor of medicine and neuroscience at NYU Grossman School of Medicine and clinical director of nephrology at NYU Langone Health, explains that for patients without a history of kidney stones, elevated results are often unremarkable. He cautions against misinterpreting calcium oxalate crystals in routine urinalysis and questions the evidence for functional medicine panels. Instead of a restrictive low-oxalate diet, Dr. Goldfarb advises patients to increase calcium intake with meals to block absorption and to limit vitamin C supplements. The article is authored by Yonathan Daniel, MD, a third-year internal medicine resident at NYU Grossman School of Medicine.
10/16/2026
Episode 177: Previewing the 2026 NEALS Annual Meeting
NeurologyLive
In a podcast interview, Jinsy A. Andrews, MD, director of the ALS Center and medical director of clinical trials at NYU Langone Health, joins Nicholas Maragakis, MD, of Johns Hopkins to preview the 2026 Network of Excellence for ALS (NEALS) Annual Meeting. They discuss the meeting's major scientific themes, emerging clinical research, and the growing focus on earlier intervention and precision medicine for amyotrophic lateral sclerosis (ALS). The conversation also covers new programming on presymptomatic ALS, updates on clinical trials, advances in trial design, and innovative therapeutic developments like gene-targeted therapies, highlighting the importance of collaboration in the field.
10/16/2026
The best types of puzzles to keep your brain sharp as you age, according to experts
Martha Stewart Living
An article exploring how different types of puzzles can keep the brain sharp during aging highlights expert opinions on the matter. According to Jordan Weiss, PhD, assistant professor in the Division of Precision Medicine and the Optimal Aging Institute at NYU Grossman School of Medicine, puzzles are a valuable tool for meaningfully engaging the brain. He notes that while research on crosswords is encouraging for those with mild cognitive impairment, it does not prove dementia prevention. Weiss also explains that jigsaw puzzles test skills like pattern recognition and mental rotation.
Also reporting was: Yahoo Health
10/16/2026
Human milk biomarkers linked to mammary function and infant growth
Technology Networks
A study led by researchers at NYU Grossman School of Medicine identified shared molecular patterns in human milk that connect maternal nutrition, mammary gland biology, and infant growth. The research, published in Science, analyzed milk samples from three diverse populations. According to senior author Liat Shenhav, PhD, assistant professor in the Department of Microbiology and the Department of Obstetrics and Gynecology at NYU Grossman School of Medicine, the findings offer a non-invasive view into the biology of the lactating mammary gland. The team identified seven biomarkers, with a short-chain acylcarnitine called C5 emerging as a key metabolic signal linked to biological processes.
10/15/2026
New thyroid disease in pregnancy guideline addresses drug regimens, screening for dysfunction
Endocrine Today
The American Thyroid Association issued its first updated guideline since 2017 on managing thyroid disease in pregnancy. Key changes include recommending against levothyroxine treatment for euthyroid women based solely on thyroid autoimmunity and providing updated guidance on antithyroid drug use for Graves’ disease. Rachel Pessah-Pollack, MD, clinical professor of medicine in the Holman Division of Endocrinology, Diabetes, and Metabolism at NYU Langone Health, commented that educating obstetricians and primary care professionals about the new recommendations will be essential for implementation. The guideline was endorsed by multiple obstetrics and endocrinology organizations.
10/16/2026
American Skin Association announces formation of ASA Emerging Dermatology Leaders Advisory Committee
Skin Inc.
The American Skin Association has formed the ASA Emerging Dermatology Leaders Advisory Committee to guide research, therapies, and patient education. Nicholas Brownstone, MD, of the Icahn School of Medicine at Mount Sinai will chair the committee. Founding members include Prince Adotama, MD, assistant professor in the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine. The committee's members, who also represent Mount Sinai and Weill Cornell Medical College, will advise on scientific opportunities and unmet needs in patient care.
10/16/2026
ASHG 2026 awards honor achievements in research, education, and more
Genetic Engineering & Biotechnology News
The American Society of Human Genetics (ASHG) is recognizing seven recipients with its 2026 Professional Awards for achievements in human genetics and genomics. Among the honorees is Aravinda Chakravarti, PhD, director of the Center for Human Genetics and Genomics, professor of medicine, and the Muriel G. and George W. Singer Professor of Neuroscience and Physiology at NYU Grossman School of Medicine, who will receive the ASHG Leadership Award. The award acknowledges his foundational contributions to population and statistical genetics, his work on complex diseases, and his leadership in major international initiatives, including the Human Genome Project.
10/16/2026
Medical Daily
New research indicates about one in 100 Medicare beneficiaries had a non-cystic fibrosis bronchiectasis diagnosis in 2023, a condition linked to high healthcare utilization. In August 2025, the FDA approved brensocatib as the first treatment for the disease. The drug reduced flare-ups by up to 21% in its phase 3 trial. Doreen J. Addrizzo-Harris, MD, director of the Bronchiectasis and NTM Program at NYU Langone Health and an investigator in the trial, said it is the first treatment to target the root cause of the condition's exacerbations.
10/16/2026
Medical students become teachers to sharpen the art of clinical reasoning
Scienmag
A new peer-teaching program developed by researchers at Yale School of Medicine, the University of California San Francisco, and NYU Langone Health aims to improve clinical reasoning among medical students. The program, detailed in the Journal of General Internal Medicine, appoints senior students to a formal leadership role as Associate Course Educators. This model has successfully tripled the number of clinical reasoning sessions and shifted them to more effective small-group formats. By expanding the pool of trained educators, the initiative addresses educational challenges in teaching diagnostic skills, a crucial step toward reducing diagnostic errors and improving patient safety.
10/16/2026
Maralixibat reduces cholestatic pruritus in Phase 3 EXPAND, with Jennifer Vittorio, MD
HCP Live
The phase 3 EXPAND trial found that the oral drug maralixibat significantly reduced cholestatic pruritus compared with a placebo in patients with rare cholestatic liver diseases, including biliary atresia. In an interview, Jennifer M. Vittorio, MD, associate professor of pediatrics and medical director of the Pediatric Liver Transplant Program at NYU Langone Health, discussed the trial’s findings. Vittorio explained that the study demonstrated a meaningful reduction in pruritus, which can translate into better sleep, improved daytime functioning, and a better quality of life for the entire family. The trial used a caregiver-reported outcome to assess itch severity in young children.
10/16/2026
Cholestatic pruritus in children: Signs, burden, and treatment gaps
HCP Live
Jennifer M. Vittorio, MD, associate professor of pediatrics and medical director of the Pediatric Liver Transplant Program at NYU Langone Health, explained that cholestatic pruritus in children is often misdiagnosed as conditions like colic or ADHD. In an interview, she detailed how symptoms vary by age, from irritability in infants to attention issues in school-aged children and social withdrawal in adolescents. Vittorio also discussed the significant burden the condition places on families and the historical ineffectiveness of off-label therapies. She noted that newer treatments, such as IBAT inhibitors, are providing better options for patients whose quality of life is severely compromised by the condition.
10/16/2026
Fracture-specific infection criteria may capture more cases than CDC infection definitions
Orthopedics Today
A study presented by Abhishek Ganta, MD, an orthopedic trauma surgeon at NYU Langone Health and associate professor in the Department of Orthopedic Surgery at NYU Grossman School of Medicine, found that a classification system for fracture-related infections (FRI) captured more cases than CDC surgical site infection definitions. Speaking at the Orthopaedic Trauma Association Annual Meeting, he reported that the FRI consensus criteria captured 100% of infections, while CDC definitions identified only 55.9%. After a 90-day period, the CDC guidelines identified zero cases, highlighting how the chosen definition materially changes reported infection rates for surveillance and research.
10/16/2026
SMU Athletics, Texas Capital partner for first statewide Power Four all-sports jersey patch
D Magazine
The NYU Grossman School of Medicine was one of four national recipients of the inaugural Patient Safety Prize from the Elevance Health Foundation. The winning organizations will collectively receive $4 million in funding to accelerate solutions aimed at improving patient safety and healthcare quality for underserved populations. Winners were chosen following a national competition focused on medication safety, fall prevention, and health literacy. Other recipients include the Parkland Center for Clinical Innovation, Care Synergy’s CAPABLE National Center, and the Public Health Institute’s Population Health Innovation Lab.
10/16/2026
Mice mirror human cerebral malaria biomarkers in new study
Scienmag
A study led by a team from NYU Grossman School of Medicine has shown that two candidate protein biomarkers for cerebral malaria behave similarly in mice as they do in humans. The research, led by Ana M. Rodriguez, PhD, professor in the Department of Microbiology at NYU Grossman School of Medicine, could accelerate the search for an early diagnostic test. The study found that the ANGPTL4 protein level correlated with disease severity, independent of parasite levels, which mirrors findings in children with cerebral malaria. The results provide a new foundation for testing potential human malaria biomarkers in mice.
10/16/2026
K-nearest neighbor algorithm for imputing missing longitudinal prenatal alcohol data
Scienmag
A research team including colleagues from NYU Grossman School of Medicinedemonstrated a machine learning solution for imputing missing data in studies of prenatal alcohol use. Writing in Advances in Drug and Alcohol Research, the team applied the k-nearest neighbor (k-NN) algorithm to data from the Safe Passage Study. This method uses pattern recognition to address gaps in self-reported alcohol consumption, which can bias research. The algorithm accurately predicted drinking status and values, offering a more reliable way to estimate prenatal alcohol exposure and its effects on fetal and infant outcomes.
10/16/2026
New MRI sequence reveals hidden auditory brainstem pathways in implant candidates
Scienmag
A new pilot study suggests a specialized MRI sequence, FGATIR, can directly visualize the anatomy of upper auditory pathways in candidates for cochlear or auditory brainstem implants, which were previously invisible on standard scans. The research, published in Frontiers in Audiology and Otology, was led by Yale University in collaboration with colleagues at NYU Grossman School of Medicine. The study found FGATIR successfully identified structural differences in the pathways of patients older than two years, which could help improve surgical planning and make outcome variability more measurable.
10/17/2026
Cancer found her for a third time. Now she is letting SILive witness her fight
Staten Island Advance
A patient's story, part of the 'Cancer on Staten Island: The Search for Why' series, details the experience of Maria Esposito, who received a second breast cancer diagnosis. The article highlights compassionate care from Deborah M. Axelrod, MD, breast surgeon at NYU Langone Health, who performed Esposito's initial lumpectomy. Dr. Axelrod personally called Esposito to deliver the news and offer comfort, which the patient found reassuring. Esposito is now preparing for a bilateral mastectomy and complex breast reconstruction. The series examines the high rates of cancer in the Staten Island borough.
10/17/2026
The One Thing: Teaching, optic nerve regeneration, and retina trainees | Episode 2
Ophthalmology Times
In a discussion on key issues facing ophthalmology, Himani Goyal, MD, clinical associate professor in the Department of Ophthalmology at NYU Grossman School of Medicine, highlights the pay discrepancy between academic and private practice physicians. Goyal states that while teaching is a 'labor of love,' the field needs to better value and compensate educators who are training the next generation. Other topics covered by experts from Mayo Clinic and the University of Rochester include the need for new methods to regenerate the optic nerve and a decline in trainee interest in the retina specialty.
10/17/2026
What is a parentified child? How to spot the signs and why they matter
Parents
Parentification happens when a child takes on adult caregiver roles before they are developmentally ready. According to Joseph D. Laino, PsyD, psychologist and clinical assistant professor at NYU Grossman School of Medicine, this dynamic can be anxiety-provoking for a child, causing feelings of insecurity. The article outlines two types, emotional and instrumental, and notes that effects can include mental health issues and difficulty forming healthy relationships in adulthood. Dr. Laino recommends acknowledging the experience, setting healthy boundaries, practicing self-care, and seeking professional help as ways to address the trauma associated with parentification.
Also reporting was: Aol, Yahoo Health, MSN New Zealand
10/17/2026
Most penicillin allergy labels are wrong, and doctors are finally removing them
Scienmag
A narrative review in the Journal of General Internal Medicine, led by researchers affiliated with NYU Grossman Long Island School of Medicine, argues that mislabeled penicillin allergies are a significant and fixable issue in antibiotic prescribing. The review notes that while one in ten patients has a penicillin allergy label, the vast majority are not truly allergic. This often leads to using less targeted and more toxic antibiotics, which increases the risk of resistant infections, lengthens hospital stays, and raises healthcare costs. The authors synthesize modern delabeling strategies and recommend integrating proactive allergy reevaluation into antimicrobial stewardship programs.
10/17/2026
Ancient somatosensory circuit architectures employ flexible molecular strategies
Scienmag
A study co-led by Jeremy S. Dasen, PhD, professor of neuroscience at NYU Grossman School of Medicine, reveals that nervous systems can maintain the same circuit architecture across vast evolutionary distances using different molecular blueprints. The research, published in iScience, examined the little skate, an early-diverging cartilaginous fish. Using advanced transcriptomics, the team found that while the spinal cord's organization is conserved, the molecular codes defining sensory neuron identity have been radically reconfigured compared to mammals. This suggests that sensorimotor systems evolve by decoupling circuit architecture from molecular specification, allowing for functional stability alongside innovation.
10/17/2026
Study links sugar intake before antibiotics to deeper gut damage
Natural News
A study by researchers at NYU Langone Health and two major cancer centers found a link between sugar intake before antibiotic use and increased gut microbiome damage. The research, published in Nature, tracked 173 hospitalized patients and discovered that every 100 grams of sugar consumed in the 48 hours prior to treatment was associated with a 21% drop in healthy gut bacteria diversity. The findings also linked sugar consumption during treatment to the spread of Enterococcus faecium, a potentially dangerous bacterium. Researchers suggest patients reduce sugar intake before and during antibiotic courses.
10/18/2026
Retirees are quietly leaving their sun-soaked havens and following their kids to this bustling city
Islands
A growing number of retirees are moving to New York City, valuing proximity to family, walkability, and access to high-quality medical care over traditional sun-soaked havens. The article highlights that New York shines in healthcare, naming NYU Langone Health as one of three city-based institutions on the U.S. News' 2026-2027 Best Hospitals Honor Roll, alongside Mount Sinai and New York-Presbyterian. Despite the city's high cost of living and other trade-offs, this demographic trend is increasing, with older adults drawn to the city's vibrant social and cultural life.
Also reporting was: Yahoo Tech, Aol
10/18/2026
The hidden bias in AI healthcare may come from clinicians, not algorithms
Scienmag
A new perspective in the *Journal of General Internal Medicine* by researchers from NYU Grossman School of Medicine argues that bias in AI healthcare often originates from clinicians' implementation rather than the algorithms. The authors, Kellie Owens, PhD, assistant professor in the Department of Population Health, Maggie Ramatowski, PhD, researcher, and Saul B. Blecker, MD, associate professor in the Departments of Population Health and Medicine, contend that even fair algorithms can yield inequitable outcomes due to how clinicians apply them. They challenge the 'human-in-the-loop' safeguard, proposing a 'system-in-the-loop' governance model.
10/18/2026
Georgia's 14th District feels healthcare cuts but voters stay loyal
Public News Service
Voters in Georgia's 14th Congressional District report facing financial strain from rising healthcare costs after enhanced Affordable Care Act subsidies expired, yet many remain loyal to Donald Trump. According to data from NYU Langone Health’s Department of Population Health, nearly 14% of residents under 65 in the district were uninsured in 2024, a figure above the national average. Despite frustration over costs, policy experts cited in the article do not anticipate a major shift in voting patterns within the deeply conservative region, where negative perceptions of the ACA persist.
10/19/2026
Landmark trial tests whether chemotherapy can be spared in high-risk early breast cancer
Scienmag
A new phase 3 clinical trial, RxFINE-Low, has been launched by the ECOG-ACRIN Cancer Research Group to determine if patients with high-anatomic-risk, low-genomic-risk early breast cancer can safely skip chemotherapy. The study is chaired by Nancy Chan, MD, amedical oncologist and director of breast cancer clinical research at NYU Langone Health’s Perlmutter Cancer Center. The trial will enroll nearly 2,000 participants with ER-positive, HER2-negative breast cancer. Patients will be randomized to either standard care with chemotherapy followed by endocrine therapy and ribociclib, or an experimental arm that omits chemotherapy, pairing endocrine therapy with ribociclib alone.
10/18/2026
I tried GLP-1 supplements for a week. I’m still hungry.
Bon Appetit
A journalist investigates GLP-1 supplements, concluding they are often just fiber powders marketed with a misleading buzzword. For expert commentary, the article consults Babak J. Orandi, MD, PhD, an obesity specialist and associate professor of surgery and medicine at NYU Grossman School of Medicine. He states there is no evidence these powders can boost GLP-1 levels or effects. He explains that medications act at concentrations thousands of times higher than the body’s own GLP-1 and are designed to last for days, making any potential boost from a supplement unlikely to have a meaningful impact.
Also reporting was: Yahoo Tech
10/16/2026
Twelve months of Medicaid after birth boosts follow-up care in high-risk mothers
Scienmag
A study in Health Affairs Scholar found that extending Medicaid coverage to 12 months postpartum measurably boosts follow-up care for high-risk mothers with diabetes or hypertensive disorders. The research, which analyzed data from New York and Texas, showed increased outpatient visits and screenings when coverage was continuous. The multi-institutional research team included Renata E. Howland, PhD, MPH, assistant professor of population health, and Andrew Tang, MPH, senior data analyst at NYU Grossman School of Medicine. The findings support the policy, now adopted by 49 states, as an effective strategy for improving long-term maternal health outcomes and preventing chronic disease.
10/17/2026
UroToday
A qualitative study co-authored by Stacy Loeb, MD, professor in the Department of Urology and the Department of Population Health at NYU Grossman School of Medicine, explored barriers and facilitators to germline genetic testing among Hispanic patients with prostate cancer. Key facilitators included family benefit, trust in clinicians, and insurance coverage. Major barriers identified were confusion with other tests, fear of negative outcomes, low awareness, and insufficient clinician-led counseling. The authors conclude that bilingual materials and greater clinician education are needed to promote equity in genetic evaluation for this patient population.
10/19/2026
I wondered if cancer was hiding in my body. So I tested for more than 50 of them.
The Washington Post
An opinion piece evaluates multi-cancer early detection (MCED) screenings, such as the Galleri test, which uses a blood sample to detect signals for more than 50 types of cancer. The author discusses his personal experience taking the test, weighing the potential for early diagnosis against the risks of false positives and false negatives. The test is currently pending full FDA approval and costs nearly $1,000. Arthur L. Caplan, PhD, an ethicist and professor emeritus at NYU Grossman School of Medicine, described it as having 'modest benefit, high cost, high risk of misuse.'
Also reporting was: The Seattle Times, Yahoo Tech, MSN New Zealand
10/17/2026
